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Abstract
Kisspeptin is a neuropeptide encoded by the kisspeptin gene (Kiss1) and located 
in different brain regions, primarily in the hypothalamus. Kisspeptin and its 
receptor G-protein-coupled receptor-54 (GPR54), are also found in behavioural 
brain regions such as the hippocampus and cortex. Kisspeptin, a very power-
ful neuropeptide that stimulates the secretion of follicle-stimulating hormone 
(FSH) and luteinizing hormone (LH) from the pituitary, does this by increasing 
gonadotropin-releasing hormone (GnRH) levels. In recent studies, it has been noted 
that kisspeptin is effective on reproductive functions. Globally 8 to 12% of couples 
have infertility problems, and the majority are residents of developing countries. 
Approximately 70% of infertility cases are caused by fertility problems in women. 
The frequency of infertility in women continues to increase every year and the 
underlying factors require further research. Bearing this problem in mind, this 
review examines the possible role of kisspeptin in female infertility. In doing so, it 
aims to find out how future application of kisspeptin may potentially unravel the 
neural reproductive disorder.
Keywords: kisspeptin, metastin, GPR54, Kiss1, Kiss1r, infertility, nitric oxide,  
sex streoid, progesterone, GnRH, LH, FSH
1. Introduction
Infertility is the inability to get pregnant despite regular sexual intercourse 
for one year or more (without contraception or the impairment of a person’s or 
a couple’s fertility) [1]. Fertility and pregnancy rates decrease due to ageing in 
women. For this reason, it is recommended that women aged 35 and above start 
receiving infertility treatment after 6 months of conception attempt. After the age 
of 40, this period should not be waited for treatment. Many factors cause female 
infertility. These can be listed as medical history (family history, previous treat-
ments, menstrual history, sexual history, etc.), physical factors (weight, body 
mass index, etc.), diminished ovarian reserves, ovulatory dysfunction (hypotha-
lamic–pituitary axis (HPG axis) disorders, ovarian disorders, thyroid disorders 
and hyperprolactinemia, etc.), tubal factors, uterine factors and unexplained 
causes [2, 3]. More than 186 million people worldwide suffer from infertility, and 
the majority of them are residents of developing countries [4].
Kisspeptin was discovered in 1996 as the product of the kisspeptin gene (Kiss1), 
which is a metastatic tumour suppressor gene; therefore, it was initially called 
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metastin [5]. Kisspeptins are a family of neuropeptides in RF-Amide structure 
[(neuropeptides containing arginine-phenylalanine (Arg-Phe) at the C-terminal are 
defined as RF-Amides)] [6]. Two years later, the connection between kisspeptin-54 
and G-protein-coupled receptor-54 (GPR54) was shown for the first time [7]. In 
2003, inactivating mutations of GPR54 were found in people with hypogonado-
tropic hypogonadism [8]. The respective receptor was previously called the GPR54, 
it is also identified as the kisspeptin receptor (Kiss1r) nowadays [9].
The detection of the role of the kisspeptin receptor mutation in leading to 
idiopathic hypogonadotropic hypogonadism paved the way for further investiga-
tions about the roles played by the kisspeptin, Kiss1, and Kiss1r systems in the field 
of reproductive endocrinology [10]. Many studies have shown that kisspeptin plays 
key roles in the regulation of different aspects of reproduction [11–17]. This review 
examines the possible role of kisspeptin in female infertility. In doing so, it aims to 
find out how future application of kisspeptin may potentially unravel the neural 
fertility disorder.
2. Kisspeptin
The Kiss1 gene encodes the neuropeptide kisspeptins. They, originally identified 
as metastasis suppressors, were later found to play a central regulatory role in repro-
duction [18]. The gene is located on human chromosome 1q32. This gene contains 
2 non-expressed and 2 partially expressed regions and four exons, assembling the 
leader peptide consisting of 145 amino acids [19]. This precursor protein transforms 
into various active forms of kisspeptin with lengths of 54, 14, 13, and 10 amino 
acids through various post-translational modifications (Figure 1) [20]. These 
forms belong to the RF-amide peptide hormone family, which is closely associated 
with energy metabolism and reproduction. The members of the RF-amide peptide 
hormone family contain the common Arg-Phe-NH2 moiety at the C-terminal [21].
Kisspeptin receptors were first discovered in 2001 in studies about cancer, and 
they were named as the GPR54. Today, they are identified as the Kiss1r [9]. Kiss1r 
is a 396-amino acid receptor and a member of G protein-coupled receptors. The 
minimum length required to activate GPR54 is a 10-amino acid carboxyl terminal 
sequence (Kisspeptin-10) [22].
3. Kisspeptin’s mechanism of action
As a result of the kisspeptin binding to the GPR54/Kiss1r receptor, activates the 
G-protein (Gq/11) and phospholipase-C (PLC). Subsequently, diacylglycerol and 
Figure 1. 
Amino acids sequence of human kisspeptin isoforms [23, 24].
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inositol trisphosphate (IP3) are formed from phosphatidylinositol bisphosphate 
(PİP2), resulting in elevated Ca+2 concentrations. Activation of this mechanism 
results in the closure of the potassium channels and opening of the cation channels 
(TRP channels), leading to the depolarization of GnRH neurons. Consequently, 
GnRH neurons start secreting hormones [25]. Kisspeptin increase apoptosis and 
decrease cell proliferation and metastasis by stimulating the mitogen-activated 
protein kinase pathway (MAPK) via protein kinase C (PKC) and the extracellular 
signal-regulated kinase (ERK) pathway (Figure 2) [26].
4. Distribution of kisspeptin neurons and effects on the HPG axis
Kisspeptin gene neurons are involved in several actions including steroid hor-
mone feedback, metabolic signalling, and photoperiodic information regulation. It 
is suggested that, compatibly with their mediator role in steroid hormone feedback 
mechanisms, Kiss1 neurons are involved in the expression of estrogen receptors 
(ERα and ERβ) and progesterone receptors [21].
Kiss1 neurons are located in the periventricular nucleus (PeN), arcuate nucleus 
(ARC) and anteroventral periventricular nucleus (AVPV) which are located in the 
preoptic area of the hypothalamus (POA) in the brain and which are the regions 
that regulate the secretion of the GnRH hormone in mouse [28]. Kisspeptins are 
secreted by these nuclei. However, AVPV displays sexual dimorphism. Kiss1 mRNA 
expression is higher in AVPV in females compared to males. This indicates that the 
role of kisspeptin neurons in AVPV varies by gender [29].
The different patterns of Kiss1 mRNA regulation in the forebrain nuclei are 
important in the emergence of the different physiological effects of Kiss1 on the 
HPG axis. ARC acts as the negative feedback regulation centre for the GnRH and 
gonadotropin secretion, while AVPV acts as the positive feedback regulation centre 
responsible for the LH surge in females. ERα, ERβ, and progesterone receptors are 
abundant in AVPV. When these receptors bind to their ligands; they increase LH 
secretion, resulting in the LH surge. Furthermore, Kiss1 neurons in AVPV synapse 
with GnRH neurons; Kiss1 mRNA expression in AVPV peaks simultaneously 
with the GnRH/LH release, and the estrogen-dependent Kiss1 mRNA induction 
in females is involved in the GnRH/LH surge during preovulation [30]. While 
gonadal steroids inhibit Kiss1 neurons in ARC (negative feedback), they stimulate 
Kiss1 neurons in AVPV (positive feedback) [23]. Signals arising from kisspeptin 
Figure 2. 
Cellular action mechanism of kisspeptins [27].
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binding to GPR54 receptors of the hypothalamic GnRH neurons induce the release 
of GnRH to the pituitary circulation. GnRH induces the release of gonadotropins 
(FSH, LH) from the pituitary by binding to the GnRH receptors in the pituitary 
gland (Figure 3) [31, 32].
The molecular mechanisms underlying the different effects of estrogen on the 
Kiss1 expression in ARC and AVPV is yet to be known. However, progesterone 
receptors are also thought to be involved in this phenomenon. Kiss1 neurons 
are colocalized with or stand very close to progesterone neurons in mouse. 
Tyrosine hydroxylase and Kiss1 mRNAs are colocalized in AVPV but not in ARC. 
Consequently, it is thought that dopamine is also involved in the induction of 
estrogen-dependent Kiss1 expression in AVPV [33].
In mouse, ARC Kiss1 neurons synthesize Tachykinin (TAC), neurokinin-B 
(NKB), and dynorphin (Dyn) in variable quantities depending on species; there-
fore, they are also known as KNDy (Kisspeptin/Neurokinin/Dynorphin) neurons. 
NKB and Dyn have been shown to mutually act on kisspeptin neurosecretion [34].
5. The effect of kisspeptin on puberty
The detection of the role of the kisspeptin receptor mutation in leading to 
idiopathic hypogonadotropic hypogonadism paved the way for studies to further 
investigate the other roles played by the Kisspeptin, Kiss1, and Kiss1r systems in the 
field of reproductive endocrinology [10]. The direct/indirect effects of kisspeptin 
on GnRH neurons leave no doubt that kisspeptin plays a critical role in pubertal 
activation. Indeed, studies on various species have shown that the Kiss1 and/or 
Kiss1r expression increases significantly with the onset of puberty [21]. In a study 
on mice, it was shown that the Kiss1 mRNA expression significantly increased in 
AVPV during puberty [35]. Also, centrally or peripherally administered kisspeptin 
in juvenile female rats shortened the timing of vaginal opening by stimulating 
LH release and ovulation [36, 37]. Similarly, the increase in kisspeptin-54 signal 
frequency in primates occur at the beginning of puberty, supporting the findings 
associated with the pubertal increase in kisspeptin secretion [38]. Kiss1 mRNA 
Figure 3. 
Kiss1 signalling in mouse brain [32].
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expression increases in ARC during puberty along with an associated increase in LH 
secretion in Rhesus monkeys [39].
Kisspeptin receptor damage impair normal sexual development and to result in 
the failure of starting puberty. Despite the synthesis of GnRH at normal levels in 
the hypothalamic GnRH neurons, LH/FSH secretions do not occur and pituitary 
gonadotropic cells remain unresponsive to externally administered GnRH in such 
cases [40]. The emergence of problems in the process of starting puberty in the 
presence of kisspeptin deficiencies has led to the idea that kisspeptin may be an 
important factor for the start of sexual maturation. This idea has been confirmed by 
significantly increased levels of released GnRH via kisspeptin injections in mam-
mals and by the acceleration of pubertal start via repeated Kisspeptin injections 
in juvenile rats. Thus, it has been proven that Kisspeptin certainly participates in 
pubertal development [41].
A cerebral antibody binds and inactivates kisspeptin in the female rats, impair-
ing or even stopping reproductive functions. Also, the administration of kisspeptin 
in fasted rats sustains the release of GnRH and that mammals suspend their repro-
ductive functions during states of long-term hunger in order to spend energy only 
enough to maintain physiological requirements. Nonetheless, the administration of 
kisspeptin reverses this natural process and restarts reproductive functions [42].
Nitric oxide (NO) is another potential mediator that can affect the onset of 
puberty since it is a mediator involved in several vital functions such as gonado-
tropin release, steroidogenesis, folliculogenesis, ovulation, luteal development, 
luteolysis, and pregnancy [43, 44]. Neuronal nitric oxide synthase (nNOS) is one of 
the three forms of an enzyme that oxidizes L-arginine to L-citrulline and NO. nNOS 
neurons in mice and rats contain high densities of ERα [45]. In rats, NO stimulates 
LH and GnRH release. In mice, deletion of nNOS causes infertility and hypogonad-
ism [46]. Furthermore, recent evidence suggests that kisspeptin may directly act on 
the release of NO. In adult female mice, kisspeptin close-contacts to nNOS neurons 
have been observed in the ARC and preoptic region; however, Kiss1r is expressed 
only from nNOS neurons in the preoptic region [47].
6. Kisspeptin in female infertility
Kisspeptin and neurokinin-B agonists can be used to stimulate the HPG axis in 
conditions associated with infertility due to central nervous system causes if the 
system of GnRH neurons is intact. Kisspeptin and neurokinin-B may offer a novel 
therapeutic approach to treat failures associated with increased/reduced gonadotro-
pin pulsatile secretion. Kisspeptins may be associated with a lower risk of ovarian 
hyperstimulation syndrome (OHSS) compared to human chorionic gonadotropin 
(hCG) injections [48]. In polycystic ovary syndrome (PCOS), kisspeptin antago-
nists can help normalize LH hypersecretion along with ovulation and follicular 
development [49].
In a study on patients with unexplained infertility (UI), PCOS, and male factor 
infertility (MFI); In PCOS group kisspeptin levels were measured and found to be 
significantly higher compared to the MFI and UI groups. The investigators sug-
gested that IU can be treated with kisspeptin injections and that high kisspeptin 
levels can be a reliable indicator to estimate the antral follicle count (AFC) and to 
diagnose PCOS [50].
In women with functional hypothalamic amenorrhea (HA) due to low body 
weight, the administration of kisspeptin-54 acutely stimulates secretion of gonado-
tropin and that the effect on gonadotropin secretion is significant after the first 
injection but diminishes considerably (tachyphylaxis) after injections for two 
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weeks [51]. Nevertheless, the frequency of injections was changed from twice a 
day to twice a week in another study, and gonadotropin response was sustained 
[52]. Eight-hour intravenous infusion of kisspeptin-54 has been shown to tempo-
rarily increase LH pulse frequency and amplitude in women with hypothalamic 
 amenorrhea [53].
Hyperprolactinemia is one of the leading causes of female infertility as it 
causes hypogonadotropic anovulation [54]. Since kisspeptin neurons have recently 
been shown to express prolactin receptors, kisspeptin has been identified as the 
key mediator involved in this system [55]. In mice, hyperprolactinemia causes 
anovulation through decreased gonadotropin and GnRH secretion and low levels 
of kisspeptin expression. Kisspeptin administration in these mice repairs ovarian 
cycle and gonadotropin secretion. It suggests that kisspeptin neurons have a role in 
hyperprolactinemic anovulation [56].
Endometriosis is a disease that causes infertility in women [57]. A study 
conducted in 2012 about endometriosis reported that Kiss1 expression could not 
be detected in any sample taken from endometriosis patients [58]. In one study, 
researchers found that the level of Kiss1 expression was statistically significantly 
higher in endometriosis lesions compared to the level determined in eutopic 
glandular endometrium and concluded that Kiss1 might have a possible role in the 
pathogenesis of endometriosis [59]. Another study reported that Kiss1r mRNA 
levels were statistically significantly higher in the cumulus cells of endometriosis 
patients compared to healthy oocyte donors. In consequence, researchers argue that 
the increased Kiss1r expression may be one of the many factors involved in the root 
cause of endometriosis and related infertility [60].
A study in women suffering from infertility, investigating the genetic associa-
tion between the neurokinin (TAC3/TAC3R) systems and kisspeptin (Kiss1/Kiss1r) 
and investigating the expression of these systems, found that the expression of 
Kiss1, TAC3, and TAC3R was downregulated in the cumulus cells. Similarly, these 
three genes have been reported to be downregulated in older women with age-
related infertility [60]. In that study, these findings could only be attributed to age 
because infertile patients were significantly older than healthy donors and because 
the endometriosis patients were younger and showed just an opposite expression 
profile compared to all other patients, including patients with age-related infertility 
and low responders [61].
7. Conclusion
This review has examined the association of kisspeptin with female infertility 
and concluded that kisspeptin has a key role in the HPG axis and can be potentially 
used for the treatment of reproductive disorders including hypogonadism, ovarian 
hyperstimulation syndrome (OHSS), polycystic ovary syndrome (PCOS), unex-
plained infertility (UI), male factor infertility (MFI), hypothalamic amenorrhea 
(HA), and endometriosis. The literature review revealed that no adverse effects 
were reported after kisspeptin administration in healthy individuals and patients. 
Therefore, kisspeptin can be used safely in both healthy and infertile individuals. 
Especially its positive effects on GnRH and its key role in the initiation of physi-
ological events in the hypothalamic–pituitary-gonadal axis (HPG axis) show that 
kisspeptin has a say in fertility. For this reason, kisspeptin is an option that should 
be focused on in the solution of infertility cases that develop in mammals (humans 
and especially livestock) and are one of the diseases of the age.
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